Prologue Journal

Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

• prologu5
• 08/09/202408/09/2024

Wall Street Journal

Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.

https://www.wsj.com/articles/merck-buying-drug-targeting-b-cell-diseases-for-up-to-1-3-billion-1bff64ee